| Literature DB >> 34922511 |
Yunqiang Cai1, He Cai1, Bing Peng2.
Abstract
BACKGROUND: Laparoscopic pancreaticoduodenectomy (LPD) is gaining popularity in last decade. However, it is still technical challenging to perform LPD for patients with large periampullary tumors.Entities:
Keywords: Anterior approach; Laparoscopy; Pancreatectomy
Mesh:
Year: 2021 PMID: 34922511 PMCID: PMC8684156 DOI: 10.1186/s12893-021-01433-7
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Fig. 1Flow diagram showing cases selected for laparoscopic pancreaticoduodenectomy via anterior approach. LPD laparoscopic pancreaticoduodenectomy
Fig. 2CT image of patient selected for laparoscopic pancreaticoduodenectomy via anterior approach. L Liver, T Tumor, SMV Superior mesenteric vein, SMA Superior mesenteric artery
Fig. 3The trocars distributions
Fig. 4The main operative procedure of laparoscopic pancreaticoduodenectomy via anterior approach. A Tumor was shown after completely taking down the hepatic flexure of colon and mesocolon transverse; B Post-pancreas tunnel was created; C The duodenum was transected by endoscopic stapler; D The gastroduodenal artery was transected; E The jejunum was transected with endoscopic stapler; F The pancreas neck was transected by ultrasonic scalpel; G The uncinate process of pancreas was dissected at the right side of superior mesenteric artery; H Anti-Kocher maneuver was carried out; I The tumor was resected and lymphadenectomy was carried out. T Tumor, P Pancreas, G Gallbladder, SMV Superior mesenteric vein, S Stomach, GDA Gastroduodenal artery, SMA Superior mesenteric artery, IVC Inferior vena cava, CHA Common hepatic artery
Demographic characteristics of patients
| Variables | Group 1 | Group 2 | P value |
|---|---|---|---|
| No. of patients | 13 | 141 | – |
| Male/female | 5/8 | 75/66 | NS |
| Age (years) | 52.7 ± 14.5 | 61.8 ± 10.2 | NS |
| BMI (kg/m2) | 23.5 ± 3.2 | 22.4 ± 2.7 | NS |
| Tumor size (cm) | 7.2 ± 2.9 | 2.4 ± 1.7 | < 0.01 |
| Pathological diagnosis | < 0.01 | ||
| IPMN | 4 | 15 | |
| SPT | 2 | 8 | |
| PNET | 2 | 6 | |
| DGST | 2 | 3 | |
| PDAC | 1 | 27 | |
| Mucinous cystadenoma | 1 | 4 | |
| Pancreatic pseudocyst | 1 | 2 | |
| DBDC | 0 | 31 | |
| DPC | 0 | 37 | |
| DA | 0 | 5 | |
| Others | 0 | 3 |
BMI Body mass index, IPMN Intraductal papillary mucinous neoplasm, SPT Pancreatic solid pseudopapillary tumors, PNET Pancreatic neuroendocrine tumors, DGST Duodenal gastrointestinal stromal tumors, PDAC Pancreatic ductal adenocarcinoma, DBDC Distal bile duct carcinoma, DPC Duodenal papillary carcinoma, DA Duodenal adenocarcinoma, NS not significant
Operative and post-operative outcomes
| Variables | Group 1 | Group 2 | P value |
|---|---|---|---|
| Operative time (min) | 356 ± 47 | 312 ± 36 | 0.02 |
| EBL (ml) | 325 ± 216 | 168 ± 72 | < 0.01 |
| Conversion (n, %) | 1, 7.7% | 3, 2.1% | NS |
| Transfusion (n, %) | 3, 23.1% | 7, 5.0% | 0.04 |
| R0 resection (n, %) | 13, 100% | 139, 98.6% | NS |
| Lymph nodes harvested | 15.8 ± 2.6 | 17.2 ± 3.5 | NS |
| POHS (days) | 12.4 ± 1.9 | 12.1 ± 2.3 | NS |
| Complications (n, %) | NS | ||
| Pancreatic fistula | |||
| Grade B | 1, 7.7% | 12, 8.5% | |
| Grade C | 0 | 1, 0.7% | |
| DGE | 1, 7.7% | 7, 5.0% | |
| Abdominal bleeding | 0 | 1, 0.7% | |
| Bile leakage | 0 | 4, 2.8% | |
| Chyle leakage | 0 | 5, 3.5% | |
| Abdominal abscess | 0 | 2, 1.4% | |
| Re-operation | 0 | 3, 2.1% | NS |
| 90-days mortality | 0 | 1, 0.7% | NS |
EBL Estimated blood loss, POHS post-operative hospital stay, DGE delayed gastric emptying, NS not significant